Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Potential Side Effects While many individuals tolerate MIC+B12 injections well, side effects can occur
It occurs when the tiny blood vessels supplying the front part of the nerve suddenly become restricted or blocked, starving the nerve tissue of oxygen
Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Atkin SL, Al-Rasadi K, et al
Important Notes Practical points that keep weekly administration safe and consistent
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
US$ 27.49
US$ 27.53
US$ 22.07
US$ 22.43
US$ 28.93
US$ 26.62
US$ 27.07
US$ 19.98
